Income Statement Astal Laboratories Limited

Stocks

MACINTR

INE307N01014

Pharmaceuticals

Delayed Bombay S.E. 01:59:16 2026-08-14 EDT			5-day change	1st Jan Change
87.50 ^INR	-0.88%		+7.02%	+0.17%

05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-14	Astal Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

96bd4d98d4542fd052e4dbc73d405.HLvz_gL0ozMsTC70HtYahm_5yFtSC74Mc83UwQIebbk.StW2j22D61ZpPX7HLKVP3yGfhSIHc9lEPKDku2BmAv5q-aeacraQQ28mTQ

Published financial data: ASTAL LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Interest and Dividend Income, Total	-	2.11M	1.79M	-	-
Interest Expense, Total	-	-	-	-	7.01M
Net Interest Income	-	2.11M	1.79M	-	-7.01M
Other Revenues, Total	2.02M	-	34.28M	237M	644M
Revenues Before Provison For Loan Losses	2.02M	2.11M	36.07M	237M	637M
Total Revenues	2.02M	2.11M	36.07M	237M	637M
Salaries And Other Employee Benefits	619K	852K	648K	-	13.38M
Cost of Services Provided, Total	128K	113K	33.79M	225M	484M
Depreciation & Amortization - (IS) - (Collected)	155K	146K	79K	295K	2.23M
Other Operating Expenses	1.05M	1.12M	1.23M	-	16.96M
Total Operating Expenses	1.95M	2.23M	35.75M	226M	517M
Operating Income	69.03K	-120K	321K	10.87M	120M
Other Non Operating Income (Expenses)	12.1K	-	-1K	-	-1K
EBT, Excl. Unusual Items	81.14K	-120K	320K	10.87M	120M
Gain (Loss) on Sale of Assets	-	-50.3K	-	-	-
EBT, Incl. Unusual Items	81.14K	-171K	320K	10.87M	120M
Income Tax Expense	20.89K	500	156K	3.02M	30.52M
Earnings From Continuing Operations	60.24K	-171K	164K	7.85M	89.25M
Net Income to Company	60.24K	-171K	164K	7.85M	89.25M
Net Income - (IS)	60.24K	-171K	164K	7.85M	89.25M
Net Income to Common Incl Extra Items	60.24K	-171K	164K	7.85M	89.25M
Net Income to Common Excl. Extra Items	60.24K	-171K	164K	7.85M	89.25M
Per Share Items
Net EPS - Basic	0.02	-0.04	0.04	1.55	9.08
Basic EPS - Continuing Operations	0.02	-0.04	0.04	1.55	9.08
Basic Weighted Average Shares Outstanding	3.97M	3.97M	3.97M	5.05M	9.83M
Net EPS - Diluted	0.02	-0.04	0.04	1.55	8.04
Diluted EPS - Continuing Operations	0.02	-0.04	0.04	1.55	8.04
Diluted Weighted Average Shares Outstanding	3.97M	3.97M	3.97M	5.05M	11.1M
Normalized Basic EPS	0.01	-0.02	0.05	1.34	7.62
Normalized Diluted EPS	0.01	-0.02	0.05	1.34	6.75
Supplemental Items
Total Revenues (As Reported)	2.03M	2.11M	36.07M	-	644M
Effective Tax Rate - (Ratio)	25.75	-0.29	48.75	27.78	25.48
Total Current Taxes	38.38K	40K	96K	2.94M	29.41M
Total Deferred Taxes	-17.48K	-39.5K	60K	82K	1.11M
Normalized Net Income	50.71K	-75.19K	200K	6.79M	74.86M
Non-Cash Pension Expense	27.12K	26.8K	171K	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	313K	183K	844K	60.76M	17.3M
Loans and Lease Receivables - (FS Template)	51.37M	51.12M	37.88M	39.92M	40.92M
Other Receivables	-	-	31.65M	158M	277M
Gross Property Plant And Equipment	1.71M	804K	804K	7.94M	118M
Accumulated Depreciation	-1.18M	-669K	-748K	-1.04M	-3.28M
Net Property Plant And Equipment	531K	135K	56K	6.9M	114M
Other Current Assets, Total	125K	170K	28.64M	48.37M	162M
Deferred Tax Assets Long-Term (Collected)	31.33K	70.9K	10K	-	-
Other Long-Term Assets, Total	706K	616K	1K	52.03M	21.65M
Total Assets	53.08M	52.29M	99.08M	366M	633M
Liabilities
Accounts Payable, Total	-	-	37.93M	115M	108M
Accrued Expenses, Total	619K	10.2K	424K	546K	412K
Current Portion of Long-Term Debt	-	-	-	548K	128M
Long-Term Debt	-	-	-	2.57M	4.56M
Current Income Taxes Payable	-	-	-	3.82M	31.31M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	697K	-	8.96M	10.03M	120K
Pension & Other Post Retirement Benefits	-	636K	-	-	-
Deferred Tax Liability Non-Current	-	-	-	72K	1.19M
Other Non Current Liabilities	-	42.3K	-	-	-
Total Liabilities	1.32M	688K	47.31M	133M	273M
Common Stock, Total	39.74M	39.74M	39.74M	98.3M	98.3M
Additional Paid In Capital	-	-	-	115M	115M
Retained Earnings	9.94M	9.78M	9.95M	17.79M	107M
Comprehensive Income and Other	2.08M	2.08M	2.08M	2.08M	39.38M
Total Common Equity	51.76M	51.6M	51.77M	233M	360M
Total Equity	51.76M	51.6M	51.77M	233M	360M
Total Liabilities And Equity	53.08M	52.29M	99.08M	366M	633M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.97M	3.97M	3.97M	9.83M	9.83M
ECS Total Common Shares Outstanding	3.97M	3.97M	3.97M	9.83M	9.83M
Book Value / Share	13.02	12.99	13.03	23.74	36.62
Tangible Book Value	51.76M	51.6M	51.77M	233M	360M
Tangible Book Value Per Share	13.02	12.99	13.03	23.74	36.62
Total Debt	0	0	0	3.12M	133M
Net Debt	-313K	-183K	-844K	-57.64M	115M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	60.24K	-171K	164K	7.85M	89.25M
Depreciation, Depletion & Amortization	155K	146K	79K	295K	2.23M
Total Depreciation, Depletion & Amortization	155K	146K	79K	295K	2.23M
(Gain) Loss On Sale of Asset - (CF)	-	-	-	-	-
Change In Inventories	-	-	-	-10.58M	-137M
Change in Accounts Payable	308K	-615K	37.93M	77.22M	-7.4M
Change in Other Net Operating Assets (Collected)	-355K	260K	-50.81M	-133M	-105M
Other Operating Activities	-2.03M	-2.11M	-1.73M	2.58M	33.27M
Cash from Operations	-1.86M	-2.49M	-14.37M	-55.9M	-125M
Capital Expenditure	-	-	-	-59.16M	-57.75M
Sale of Property, Plant, and Equipment	-	250K	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-20.65M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-2.05M	-1M
Other Investing Activities, Total	2.03M	2.11M	1.79M	134K	1.25M
Cash from Investing	2.03M	2.36M	1.79M	-61.08M	-78.14M
Long-Term Debt Issued, Total	-	-	13.24M	3.3M	3.17M
Total Debt Issued	-	-	13.24M	3.3M	3.17M
Long-Term Debt Repaid, Total	-	-	-	-174K	-547K
Total Debt Repaid	-	-	-	-174K	-547K
Issuance of Common Stock	-	-	-	174M	-
Other Financing Activities, Total	-	-	-	-	30.29M
Cash from Financing	-	-	13.24M	177M	32.91M
Miscellaneous Cash Flow Adjustments	-	-	1K	-	-
Net Change in Cash	168K	-130K	661K	59.92M	-170M
Supplemental Items
Cash Interest Paid	-	-	-	-	7.01M
Cash Income Tax Paid (Refund)	20.89K	500	96K	300K	3.01M
Net Debt Issued / Repaid	-	-	13.24M	3.12M	2.62M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.11	-0.32	0.22	3.37	17.86
Return On Equity %	0.12	-0.33	0.32	5.5	30.08
Return on Common Equity	0.12	-0.33	0.32	5.5	30.08
Margin Analysis
Gross Profit Margin %	100	100	6.99	5.57	24.22
SG&A Margin	37.01	45.78	2.48	0.85	2.39
Income From Continuing Operations Margin %	2.98	-8.12	0.45	3.32	14.02
Net Income Margin %	2.98	-8.12	0.45	3.32	14.02
Net Avail. For Common Margin %	2.98	-8.12	0.45	3.32	14.02
Normalized Net Income Margin	2.51	-3.57	0.55	2.87	11.76
Asset Turnover
Asset Turnover	0.04	0.04	0.48	1.02	1.27
Short Term Liquidity
Current Ratio	39.36	5.05K	2.09	2.36	1.86
Quick Ratio	39.27	5.03K	1.49	1.99	1.25
Operating Cash Flow to Current Liabilities	-1.42	-243.93	-0.3	-0.43	-0.47
Long Term Solvency
Total Debt/Equity	-	-	-	1.34	36.86
Total Debt / Total Capital	-	-	-	1.32	26.93
LT Debt/Equity	-	-	-	1.1	1.27
Long-Term Debt / Total Capital	-	-	-	1.09	0.93
Total Liabilities / Total Assets	2.48	1.32	47.75	36.25	43.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.01	3.79	1.61K	556.01	169.15
Gross Profit, 1 Yr. Growth %	-0.01	3.79	19.64	1.36K	567.15
Earnings From Cont. Operations, 1 Yr. Growth %	-121.4	-384.22	-195.91	4.68K	1.04K
Net Income, 1 Yr. Growth %	-121.4	-384.22	-195.91	4.68K	1.04K
Normalized Net Income, 1 Yr. Growth %	-128.86	-248.33	-366.67	3.3K	1K
Diluted EPS Before Extra, 1 Yr. Growth %	-121.4	-384.22	-195.29	3.69K	417.71
Common Equity, 1 Yr. Growth %	0.12	-0.31	0.32	350.85	54.22
Total Assets, 1 Yr. Growth %	0.7	-1.48	89.47	269.53	73
Tangible Book Value, 1 Yr. Growth %	0.12	-0.31	0.32	350.85	54.22
Cash From Operations, 1 Yr. Growth %	-6.17	33.57	477.45	289.09	124.35
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-2.39
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-17.8	2.18	321.43	959.45	320.1
Gross Profit, 2 Yr. CAGR %	-17.8	2.18	11.44	150.09	1.21K
Earnings From Cont. Operations, 2 Yr. CAGR %	-72.91	-22.04	65.05	577.41	2.23K
Net Income, 2 Yr. CAGR %	-72.91	-22.04	65.05	577.41	2.23K
Normalized Net Income, 2 Yr. CAGR %	-67.19	-34.59	98.64	851.58	1.83K
Diluted EPS Before Extra, 2 Yr. CAGR %	-73.13	-22.04	64.52	500.88	1.3K
Common Equity, 2 Yr. CAGR %	-0.21	-0.1	0.01	112.67	163.69
Total Assets, 2 Yr. CAGR %	-0.22	-0.4	36.63	164.61	152.84
Tangible Book Value, 2 Yr. CAGR %	-0.21	-0.1	0.01	112.67	163.69
Cash From Operations, 2 Yr. CAGR %	-21.23	11.95	177.72	374.01	195.17
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-12.28	-10.98	161.42	388.42	570.9
Gross Profit, 3 Yr. CAGR %	-12.28	-10.98	7.7	86.55	318.21
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.01	-40.72	-16.48	407.03	705.15
Net Income, 3 Yr. CAGR %	-3.01	-40.72	-16.48	407.03	705.15
Normalized Net Income, 3 Yr. CAGR %	20.15	-45.76	4.41	411.7	899.37
Diluted EPS Before Extra, 3 Yr. CAGR %	-8.82	-41.03	-16.66	368.09	471.77
Common Equity, 3 Yr. CAGR %	-0.66	-0.24	0.04	65.21	91.07
Total Assets, 3 Yr. CAGR %	-0.63	-0.64	23.41	90.36	129.66
Tangible Book Value, 3 Yr. CAGR %	-0.66	-0.24	0.04	65.21	91.07
Cash From Operations, 3 Yr. CAGR %	-13.59	-6.07	93.43	210.75	269.16
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-7.99	-7.1	64.54	139.74	216.04
Gross Profit, 5 Yr. CAGR %	-7.99	-7.1	-3.35	34.57	138.01
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.89	26.98	19.96	57.06	216.39
Net Income, 5 Yr. CAGR %	-5.89	26.98	19.96	57.06	216.39
Normalized Net Income, 5 Yr. CAGR %	-24.34	2.41	46.9	70.51	235.65
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.39	33.91	15.44	49.22	157.65
Common Equity, 5 Yr. CAGR %	-0.4	-0.48	-0.4	35.03	47.42
Total Assets, 5 Yr. CAGR %	-0.14	-0.66	12.87	47.02	64.42
Tangible Book Value, 5 Yr. CAGR %	-0.4	-0.48	-0.4	35.03	47.42
Cash From Operations, 5 Yr. CAGR %	-4.29	-3.88	37.84	79.47	129.06
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-